Pregled bibliografske jedinice broj: 655938
Perioperative coagulation disorders in cancer patients, impact of thromboprophylaxis
Perioperative coagulation disorders in cancer patients, impact of thromboprophylaxis // 6th Slovenian congress of anaesthesiologists, Ljubljana, May 10th-12th, 2013: Proceedings / Novak Jankovič, Vesna (ur.).
Ljubljana: Slovenian Society of Anaesthesiology and Intensive Care Medicine, Slovenian Medical Association, 2013. str. 65-69 (predavanje, recenziran, cjeloviti rad (in extenso), znanstveni)
CROSBI ID: 655938 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Perioperative coagulation disorders in cancer
patients, impact of thromboprophylaxis
Autori
Bagatin, Dinko ; Šakić, Katarina ; Šturm, Deana ; Šakić, Livija ; Bagatin, Tomica
Vrsta, podvrsta i kategorija rada
Radovi u zbornicima skupova, cjeloviti rad (in extenso), znanstveni
Izvornik
6th Slovenian congress of anaesthesiologists, Ljubljana, May 10th-12th, 2013: Proceedings
/ Novak Jankovič, Vesna - Ljubljana : Slovenian Society of Anaesthesiology and Intensive Care Medicine, Slovenian Medical Association, 2013, 65-69
ISBN
978-961-6404-26-6
Skup
6th Slovenian Congress of Anaesthesiologists
Mjesto i datum
Ljubljana, Slovenija, 10-12.05.2013
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Recenziran
Ključne riječi
cancer ; coagulation disorders ; surgery ; thrornboprophylaxis
Sažetak
Background: Coagulation disorders may have a significant impact on the clinical outcomes in cancer population as a consequence of tumor growth, chemotherapy, radiotherapy or due to the surgical trauma. Surgery promotes the formation of fibrin and platelet clots around tumor cell emboli, thereby impairing natural killer cell- mediated tumor cell clearance, whereas perioperative anticoagulation attenuates this effect. Undergoing surgical procedure presents an additional stress for the organism. Coagulation and anticoagulation inhibitor values analysis of perioperative measurements should have answered questions about a pathophysiological processes that are activated during the operation, but which are also blocked by applied Low molecular weight heparines, which has an antithrombin' profibrinolytic and antiaggregational effect. Changes in coagulation and fibrinolysis inhibitor activity can perioperatively cause trombosis and/or bleeding. Awareness of underlying mechanisms should point to preventive strategies, early diagnostics, and appropriate treatment of cancer and coagulation disorders associated. By activating t-PA and blocking PAI-1, thromboprophylaxis with LMW Heparin creates a stable and balanced perioperative system of haemostasis. Those may have a significant impact on the clinical outcomes in this suspectible population. Conclusion: The site of injury, as well as in haemophilia, thrombocytopenia, functional deficits of thrombocites and major bleeding due to trauma and surgery in cancer patients increases thrombin generation. The resulting clot is resistant to locally activated fibrinolysis. By activating t-PA and blocking PAI- I, thromboprophylaxis with Low molecular weight heparines (LMWH) creates a stable and balanced perioperative system of haemostasis.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
MZOS-108-0000000-3433 - Imunosni odgovor na kirurški stres u regionalnoj i općoj anesteziji (Šakić, Kata, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb